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The aim of this article is to review the role of uric acid in 
the context of antioxidant effects of wine and its potential 
implication to human health. We described and discussed 
the mechanisms of increase in plasma antioxidant capacity 
after consumption of moderate amounts of wine. Because 
this effect is largely contributed by acute elevation in plas-
ma uric acid, we paid special attention to wine constitu-
ents and metabolic processes that are likely to be involved 
in uric acid elevation.
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The association between light-to-moderate wine con-
sumption and risk reduction of cardiovascular diseases 
and/or reduction of all-cause mortality was confirmed 
by numerous epidemiological studies (1-7). Among other 
beneficial biological effects, it has been shown that wine 
can increase antioxidant capacity in humans (8-12) and re-
duce susceptibility of human plasma to lipid peroxidation 
(11,13). These effects of wine attracted significant research 
interest, as oxidative stress is implicated in the pathogen-
esis of various diseases such as cancer and cardiovascular 
and neurodegenerative diseases (14-19).
Wine anD plasMa antioxiDant capacity
Early studies by St Leger et al (3) and Renaud et al (4) dem-
onstrated an inverse relation between incidence of coro-
nary heart disease and wine consumption in different de-
veloped countries, which prompted the efforts to discover 
the mechanisms underlying the observed effects. Soon, it 
was recognized that polyphenolic compounds highly con-
tained in wine, especially in red wine, were responsible for 
various biological effects, including potent antioxidative 
activity.
Antioxidative activity of polyphenols is based on two 
mechanisms: chelation of free metal atoms such as iron 
and copper, which prevents biochemical reactions gener-
ating reactive oxygen species and scavenging of free radi-
cals as effective hydrogen donors (20). Indeed, Frankel et al 
showed in 1993 that red wine phenolics inhibited oxida-
tion of human low-density lipoprotein in vitro (21).
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An increase in serum antioxidant activity following inges-
tion of red wine was first described in 1994 by Maxwell et 
al (8). In a similar study, Whitehead et al (9) showed that 
serum antioxidant capacity one hour after ingestion of 300 
mL of red wine increased by 18%, which was comparable 
with 22% increase in serum antioxidant capacity after in-
gestion of 1 g of vitamin C.
Serafini et al (10,11), who studied the relationship between 
polyphenols content and antioxidant capacity of beverag-
es with plasma levels of polyphenols and its antioxidant 
capacity, provided a deeper insight into this matter. Their 
studies with dealcoholized red and white wine and green 
and black tea demonstrated that total antioxidant capacity 
of plasma was associated with plasma total polyphenols 
concentration.
More recent analytical methods and kinetic studies, how-
ever, showed that polyphenols from food, including wine, 
were poorly absorbed in humans (22-24). The net increase 
in plasma polyphenols concentration after red wine con-
sumption is insufficient to explain the observed elevation 
in plasma antioxidant capacity. Day and Stansbie (25) were 
first to propose an alternative explanation for the antioxi-
dant effects of red wine. They reported a significant cor-
relation between the increase in total serum antioxidant 
capacity and the increase in serum urate concentration 
after port wine consumption. This finding was later sup-
ported by Maxwell and Thorpe (8), who reanalyzed their 
results published in 1994 and reported that more than half 
of red wine-induced increase in antioxidant capacity in 
their study could be attributed to changes in serum urate 
(26). A recent study by our group demonstrated that acute 
elevation of plasma antioxidant capacity after red wine 
consumption was mediated by two separate factors, wine 
phenols and plasma urate (12).
It should be noticed that ethanol, as an important con-
stituent of wine implicated in its various biological effects, 
does not contribute directly to the wine-related acute in-
crease in plasma antioxidant capacity. On the contrary, 
there was a decrease in plasma antioxidant capacity af-
ter ethanol ingestion, indicating an ethanolic-mediated 
oxidative load (12,27). However, ethanol might be indi-
rectly involved in plasma antioxidative activity after wine 
consumption. Even small changes in physical-chemical 
properties of hydroalcocholic solutions in which poly-
phenols are dissolved significantly influence their solu-
bility, precipitation behavior, and their interactions with 
proteins, which in turn may influence their biochemical 
properties and bioavailability (11,28-30). Indeed, Duthie et 
al (27) showed that proportionally more phenolics were 
absorbed from whisky than from wine, which was partly 
ascribed to the greater ethanol content of whisky that aids 
phenolics absorption.
One more aspect of wine-related increase in plasma anti-
oxidant activity should be mentioned, and that is the effect 
of unabsorbed polyphenols that remain in gastrointestinal 
system following the wine consumption. There they can 
scavenge free radicals locally, preventing lipid peroxidation 
and, at the same time, spare other antioxidants from oxida-
tion. In such a way, although acting locally, the polyphe-
nols could influence the whole organism and the plasma 
concentration of various antioxidants, which in turn could 
affect plasma antioxidant capacity (31-33). Moreover, red 
wine polyphenols have recently been attributed a new 
beneficial function: prevention of absorption of cytotoxic 
lipid peroxidation products (34).
MecHanisMs oF Wine-inDUceD eleVation in 
plasMa URic aciD
When it was determined that acute elevation of plasma 
uric acid after red wine consumption largely contributed 
to the observed increase in plasma antioxidant capacity, a 
new question was raised: Which wine component(s) is/are 
responsible for acute postprandial increase in plasma uric 
acid concentration and related antioxidant capacity?
Because polyphenols-stripped red wine caused an increase 
in plasma urate similar to that of the intact red wine (12,35), 
it could be concluded that the observed effect is polyphe-
nols-independent. On the other hand, consumption of de-
alcoholized red wine did not cause an increase in plasma 
urate, pointing to the role of ethanol in the phenomenon 
(12,36). After ingestion of different combinations of non-
phenolic constituents of wine (organic acids, sugars, glyc-
erol), the increase in plasma urate and related antioxidant 
capacity was successfully replicated by a mixture of glyc-
erol in ethanol-water solution. There was no glycerol effect 
if ethanol was removed from the solution (37).
The detailed biochemical mechanism responsible for this 
effect is yet to be revealed. Nevertheless, by linking our 
results to the findings of Lundquist et al (38) and Thiden 
(39) on metabolic interactions of glycerol and ethanol in 
humans and in isolated liver slices, we propose credible 
explanation of the metabolic processes responsible for 
the described effect.
REVIEW18 Croat Med J. 2010; 51: 16-22
www.cmj.hr
Almost 45 years ago, Lundquist et al (38) demonstrated that 
there was a significant reduction (up to 70%) in the uptake 
of glycerol in the splanchnic area in humans when glycerol 
and ethanol were infused together. On the other hand, no 
changes in the rate of ethanol metabolism or in the output 
of acetate from the liver were observed when ethanol was 
infused either alone or in combination with glycerol. Based 
on the available information at the time, an explanation for 
the observed inhibition of glycerol metabolism by ethanol 
was offered. It was proposed that dihydroxyaceton phos-
phate formed by oxidation of glycerophosphate might be 
reduced back to glycerophosphate by nicotinamide ad-
enine dinucleotide (reduced form), which is produced in 
surplus by ethanol metabolism in liver tissue (Figure 1). 
Consequential accumulation of glycerophosphate could 
be the cause of the inhibitory effects of ethanol in the first 
step of glycerol metabolism, ie, inhibition of glycerol phos-
phorilation to glycerophosphate.
Related changes in adenine nucleotides turnover and plas-
ma uric acid, as a result of ethanol-glycerol metabolic inter-
actions, were not envisioned at that time.
Four years later, in experiments using isolated liver slices, 
Thieden (39) showed that the addition of ethanol to the 
incubation medium containing glycerol caused a decrease 
in glycerol uptake by more than 40%, and the highest ac-
cumulation of glycerophosphate was observed in the slic-
es incubated in the medium containing both glycerol and 
ethanol. However, this study resulted in another impor-
tant finding – a significant depletion of adenosine triphos-
phate and total adenine nucleotides content only in the 
liver slices incubated with glycerol and ethanol. A possible 
meaning of this finding was not addressed in the article. 
Our finding that uric acid acutely rises after consumption 
of ethanol and glycerol indirectly confirms the validity of 
Thieden’s results, indicating that lost adenine nucleotides 
were metabolized to uric acid. Described metabolic inter-
actions are shown in more detail in the modified and up-
dated scheme after Lundquist et al (Figure 1).
A sharp distinction should be drawn between short-term 
effects of moderate amount of wine (ethanol and glycerol) 
consumption on plasma uric acid and ethanol-induced hy-
peuricemia.
It is rather well documented that ethanol by itself may 
induce hyperuricemia, which is mediated by both, a de-
creased renal excretion of uric acid as a result of increased 
blood lactate level (40,41) and an elevated production of 
urate that is secondary to enhanced turnover of adenine 
nucleotides (42-44).
The ethanol-induced hyperuricemia, however, occurs after 
the intake of much higher amounts of ethanol during pro-
longed period of time (40,42), and as such should not be 
confused with the acute elevation of plasma urate follow-
ing the intake of moderate amounts of wine.
Indeed, oral intake of ethanol in amounts equivalent to 
those contained in 200-300 mL of red wine did not cause 
changes in plasma uric acid level for at least 3 hours (12). 
Moreover, two-hour intravenous administration of ethanol 
Figure 1.
proposed biochemical mechanism of increased uric acid production induced by glycerol 
and ethanol (modified and updated after lundquist et al (38). aMp – adenosine monophos-
phate; aDp – adenosine diphosphate; atp – adenosine triphosphate; naD – nicotinamide 
adenine dinucleotide; naDH – nicotinamide adenine dinucleotide (reduced form); ac. coa 
– acetyl-coenzyme a; α-Gly-p – α-glycerophosphate; DHap – dihydroxyacetone phosphate, 
ox. pH – oxidative phosphorylation. ethanol is first oxidized to acetaldehyde, which is fur-
ther oxidized to acetate. During these two oxidation steps, a parallel reduction of two mol-
ecules of naD to naDH occurs. this generation of reducing equivalents in the liver is as-
sociated with atp synthesis. acetate is metabolized to acetyl-coa via acetyl-aMp. During 
conversion of acetate to acetyl-aMp to acetyl-coa, atp is dephosphorylated to aMp; thus 
2 mol of high-energy phosphate are consumed for each mol of ethanol metabolized. al-
though most of the aMp formed is resynthesized to atp, a small amount of aMp may enter 
the pathway of adenine nucleotide degradation leading to uric acid production. atp formed 
during ethanol oxidation to acetate is inhibitory to the adenine nucleotide degradation. 
the first step in glycerol metabolism is phosphorylation to α-glycerophosphate associated with 
dephosphorylation of atp to aDp. the produced α-glycerophosphate is then oxidized to dihy-
droxyacetone phosphate (DHap), which can be directed to production of glycogen (glucose) or 
pyruvate (lactate). in the presence of sufficient amounts of naDH, largely produced during eth-
anol metabolism, dihydroxyacetone phosphate can be reduced back to α-glycerophosphate. 
the net result of redirecting naDH to the production of α-glycerophosphate instead of atp 
would be increased adenine nucleotide degradation and production of uric acid.
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to human participants, at 0.25 to 0.35 g per kilogram per 
hour, did not cause substantial alterations in serum urate 
levels, urate clearance, and urinary uric acid excretion rela-
tive to the baseline values (42).
acUte HypeRURiceMia anD caRDioVascUlaR 
eFFects
Uric acid is an end product of purine metabolism in hu-
mans. This is different than in most other mammals, which 
express urate oxidase, an enzyme responsible for further 
metabolism of uric acid to allantoin. During the course 
of human evolution, several mutational events have pro-
duced the loss of uricase activity (45). This, in addition to ef-
fective kidney re-absorption system for urate, has resulted 
in approximately 10 times higher plasma uric acid levels in 
humans than in most other mammals (46,47), indicating 
biological significance of uric acid in man.
Indeed, uric acid is the most abundant aqueous antioxi-
dant, accounting for up to 60% of plasma antioxidative 
capacity (48). The antioxidative effect of uric acid is evi-
denced by its ability to directly scavenge free radicals (49) 
or to form stable complexes with transition-metal ions, 
such as iron, thereby preventing ascorbate oxidation and 
lipid peroxidation (50,51).
Consequently, administration of uric acid increased plas-
ma antioxidant capacity (52) and reduced exercise-associ-
ated oxidative stress in healthy participants (53,54). Also, 
the acute elevation of plasma uric acid protected endo-
thelial function in patients with type 1 diabetes and reg-
ular smokers (55), and protected from hyperoxia-induced 
oxidative stress and increase in arterial stiffness in healthy 
humans (56). It is interesting that the beneficial effects in 
the mentioned studies were induced by uric acid elevation 
ranging from 15 to 100% relative to the control values, indi-
cating the possibility of a threshold in the uric acid-medi-
ated effects on vascular function.
conclUDinG iMplications
Acute, moderate elevation of plasma uric acid largely con-
tributes to the increase in total plasma antioxidant capac-
ity after red wine consumption (8,9,12). The elevation in 
plasma uric acid is mediated by two alcohols in wine, etha-
nol and glycerol (37).
Here, we propose an explanation of the metabolic pro-
cesses that are likely to be involved in the phenomenon, 
although the exact underlying mechanism is yet to be 
proved.
Epidemiological findings that the chronic hyperuricemia 
is a marker of increased cardiovascular risk (57-59) should 
not be confused with the cardiovascular effects of acute, 
transient increase in plasma uric acid. Acute hyperuricemia 
even at high concentrations and under different experi-
mental conditions did not cause harmful cardiovascular 
effects in human participants. On the contrary, it reduced 
exercise-associated oxidative stress (53,54), protected en-
dothelial function in patients with type 1 diabetes and reg-
ular smokers (55), and protected from hyperoxia-induced 
oxidative stress and increase in arterial stiffness (56), while 
lowering serum urate did not improve endothelial function 
in patients with type 2 diabetes (60). It should also be men-
tioned that acute actions of established cardiovascular risk 
factors, such as high-fat meals, hyperhomocysteinemia, or 
cigarette smoking, cause immediate impairment of vascu-
lar function (61-63), in contrast to acutely increased plasma 
uric acid.
Different mechanisms have been proposed as explana-
tions of paradoxical associations of uric acid (64-68), but 
the role of uric acid as a causal, compensatory, or coinci-
dental risk factor remains unclear.
Although chronic hyperuricemia is associated with gout 
(69) and ethanol intake is a well-established risk factor (44), 
recent epidemiological studies have shown that moder-
ate consumption of wine is not associated with higher in-
cidence of gout, in contrast to consumption of beer and 
spirits (70,71).
Taken together, we can conclude that acute plasma urate 
increase after wine consumption is not likely to cause detri-
mental effects to human health associated with chronic hy-
peruricemia. Quite the opposite, if wine is consumed with 
meals, the timed elevation of plasma uric acid may signifi-
cantly contribute to the wine’s protective effects against 
postprandial oxidative stress (13). Indeed, in the most re-
cent review by Covas et al (72), who analyzed the studies 
on moderate wine consumption and oxidative damage in 
humans, protective effects of wine were most convincing 
during the meal-related postprandial oxidative stress. In 
line with this is the finding of a epidemiological study that 
showed that cardioprotective effects of wine intake were 
observed only in participants who consumed wine with 
meals, but not in those who consumed wine separate 
from the food intake (73).
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